AVENTAMED DESIGNATED ACTIVITY COMPANY

AventaMed Designated Activity Company is an Irish medical-technology firm that has pioneered a new approach to ear-tube placement for children. Its flagship product, the Solo+™ Tympanostomy Tube Device (TTD), enables the procedure to be performed with as little as topical anaesthesia, meaning the child can stay awake, avoid fasting and return to normal activities almost immediately. By eliminating the need for a sterile operating-room environment and reducing the use of general anaesthesia, Solo+™ also cuts procedure time and lowers greenhouse-gas emissions.

The company's solution is aimed at three key groups - patients, parents and physicians - offering a clear, quick and child-friendly alternative to the traditional surgical method. Benefits highlighted include parental presence during the procedure, a streamlined check-in process and a rapid discharge, all while maintaining the high safety standards required for paediatric otology.

Based in Cork, AventaMed is now part of the Karl Storz family of medical-technology companies, reinforcing its commitment to innovative, sustainable ear-care solutions for clinicians and families across Ireland and beyond.